showed that high Sp1 expression levels were correlated to cervical cancer progression, and that knockdown of Sp1 significantly enhanced the cellular response to radiation by inducing G2/M arrest, suggesting that Sp1 might represent a potential therapeutic target in cervical cancer [126]. This evidence concerns the gene SP1 and cervical cancer.